Department of Integrative Bioscience, Oregon Health and Science University, Portland, Oregon, United States.
Bosn J Basic Med Sci. 2021 Oct 1;21(5):535-541. doi: 10.17305/bjbms.2020.5407.
Medullary thyroid carcinoma (MTC) is a relatively rare thyroid carcinoma of C-cell deviation and produces and secrete calcitonin (CT) and chromogranin A (CgA) into the blood. Thus, both CT and CgA are immunohistochemical and serum markers for MTCs. MTC occurs in both sporadic and inheritable cases and the hallmark of inheritable cases in multiple endocrine neoplasm 2 (NEN2) is MTC. MEN2 cases represent 30% of MTCs through germline RET protooncogene mutation and occur in younger ages involving bilateral thyroid lobes. Sporadic cases are 70% of cases of solitary tumor and occur in older ages. CgA and synaptophysin (SPY) are the two, most widely used and reliable immunohistochemical markers for neuroendocrine tumors including MTCs. This study aimed to detect different immunohistochemical staining patterns for CgA and SPY between non-symptomatic small, microscopic lesions and invading larger aggressive tumors in both MEA2 cases and sporadic cases. There was different CgA and SPY immunostaining in MEA2 cases where small tumors (≤ 0.3 cm) were lesser immunostained for CgA and SPY, despite strong staining for CT, compared to the larger (≥ 0.5cm) tumors, stronger immunostained for CgA. There was also different CgA and SPY immunohistochemical staining in sporadic cases between small lesion (≤ 0.5 cm) and larger tumors (≥ 1.0cm). One small sporadic tumor (0.5 x 0.3 cm) was strongly and weakly, patchy (about 10% of tumor tissue) stained for CgA and SPY, respectively, while larger sporadic tumors were diffusely, stronger stained for CgA and SPY. Therefore, stronger CgA and SPY immunostaining for larger tumors in both MEA2 and sporadic cases may be used as independent aggressive immunohistochemical markers for MTCs.
甲状腺髓样癌(MTC)是一种相对罕见的 C 细胞来源的甲状腺癌,其在血液中产生和分泌降钙素(CT)和嗜铬粒蛋白 A(CgA)。因此,CT 和 CgA 都是 MTC 的免疫组织化学和血清标志物。MTC 发生于散发性和遗传性病例中,多发性内分泌肿瘤 2 型(MEN2)的遗传性病例的标志是 MTC。MEN2 病例通过种系 RET 原癌基因突变占 MTC 的 30%,发生在更年轻的年龄,涉及双侧甲状腺叶。散发性病例占 70%的孤立肿瘤,发生在更年长的年龄。CgA 和突触素(SPY)是两种最广泛使用和可靠的用于包括 MTC 在内的神经内分泌肿瘤的免疫组织化学标志物。本研究旨在检测 MEA2 病例和散发性病例中无症状的小、显微镜下病变和侵袭性较大的肿瘤之间 CgA 和 SPY 的不同免疫组织化学染色模式。MEA2 病例中,较小的肿瘤(≤0.3cm)的 CgA 和 SPY 免疫染色较弱,尽管 CT 染色较强,与较大的肿瘤(≥0.5cm)相比,CgA 免疫染色较强。散发性病例中,较小的病变(≤0.5cm)和较大的肿瘤(≥1.0cm)之间也存在 CgA 和 SPY 免疫组织化学染色的差异。一个小的散发性肿瘤(0.5x0.3cm)分别强烈和弱地、斑驳地(约 10%的肿瘤组织)染色 CgA 和 SPY,而较大的散发性肿瘤弥漫地、更强地染色 CgA 和 SPY。因此,MEA2 和散发性病例中较大肿瘤的 CgA 和 SPY 免疫染色增强可能作为 MTC 的独立侵袭性免疫组织化学标志物。